Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2000
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047729A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047558A1 Amide compounds and medicinal use thereof
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047210A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047189A1 Pharmaceutical effervescent formulation containing metamizol
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015231A9 Adenosine a3 receptor modulators
08/17/2000WO2000014262A9 Methylation of plasmid vectors
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2360164A1 5-ht1f agonists
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028137A2 Polymeric matrices and their uses in pharmaceutical compositions
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/16/2000EP1027894A2 Pharmaceutical preparation for the treatment of inflammatory processes
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027432A2 RIBOZYMES TARGETED TO IL-15 mRNA
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
08/16/2000EP1027325A2 Lipophilic diesters of chelating agents
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027052A1 Novel combination
08/16/2000EP1027038A1 Taste masked pharmaceutical compositions
08/16/2000EP0883628B1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
08/16/2000EP0869965B1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs
08/16/2000EP0584108B1 Pharmaceutical composition comprising ibuprofen salt
08/16/2000CN1263522A Compounds and methods for inhibition of expression of VCAM-1
08/16/2000CN1263464A Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
08/16/2000CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease
08/16/2000CN1263087A Substituted alkyl tetramine derivative
08/16/2000CN1262954A Homothermal adhesive plaster promoting blood circulation to stop pain
08/16/2000CN1262953A Monosaccharidase analgesic oral liquor
08/16/2000CN1262952A Chinese herbal medicinal liquor for curing rheumatic arthritis
08/16/2000CN1262951A Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method
08/16/2000CN1262935A Medicated wine for curing rheumatism and rheumatoid disease and its preparing method
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/16/2000CN1055396C Method for producing medicinal liquor for curing arthritis
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103739 Metalloproteinase inhibitors
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/15/2000US6103718 Selective cyclic nucleotide phosphodiesterase (pde) inhibitors (specifically of type 4) which are effective bronchial therapeutics; bronchodilators; respiratory system disorders
08/15/2000US6103711 Inhibitors of interleukin-1β converting enzyme
08/15/2000US6103702 Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2)
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/15/2000CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same
08/15/2000CA2136553C 7-(2-aminoethyl)-benzothiazolones
08/15/2000CA2046883C Heterocyclic derivatives, method for preparing same, and their therapeutic applications
08/10/2000WO2000046371A1 Tau-conotoxin peptides
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046203A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000WO2000046199A2 Indole derivatives as anti-inflammation agents
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1272